within Pharmacolibrary.Drugs.ATC.R;

model R05CB13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.04,
    adminDuration  = 600,
    adminMass      = 0.0025,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Dornase alfa is a recombinant form of human deoxyribonuclease I (rhDNase) used to break down extracellular DNA in the sputum of cystic fibrosis patients, thereby reducing sputum viscosity and improving pulmonary function. It is approved as a mucolytic therapy primarily in cystic fibrosis and remains in current clinical use.</p><h4>Pharmacokinetics</h4><p>PK parameters described for cystic fibrosis patients, both adult and pediatric, following standard inhalation administration.</p><h4>References</h4><ol><li><p>Witt, DM, &amp; Anderson, L (1996). Dornase alfa: a new option in the management of cystic fibrosis. <i>Pharmacotherapy</i> 16(1) 40–48. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8700791/&quot;>https://pubmed.ncbi.nlm.nih.gov/8700791</a></p></li><li><p>Burness, CB, &amp; Keating, GM (2012). Mannitol dry powder for inhalation: in patients with cystic fibrosis. <i>Drugs</i> 72(10) 1411–1421. DOI:<a href=&quot;https://doi.org/10.2165/11208950-000000000-00000&quot;>10.2165/11208950-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22755516/&quot;>https://pubmed.ncbi.nlm.nih.gov/22755516</a></p></li><li><p>Rubin, BK (2007). Mucolytics, expectorants, and mucokinetic medications. <i>Respiratory care</i> 52(7) 859–865. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17594730/&quot;>https://pubmed.ncbi.nlm.nih.gov/17594730</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R05CB13;
